• About
  • Board
  • News
  • Sign Up
  • Contact

Visit

VJHemOnc
Logo
  • Home (current)
  • Diseases
    ALL
    AML
    CLL
    Lymphoma
    Multiple Myeloma
    Myeloproliferative Neoplasms
    View all Diseases
  • Topics
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    Transplantation
    View all Topics
  • Conferences
    EBMT-EHA
    CAR T-Cell Meeting
    2019
    ASH
    2018
    UKONS
    2018
    ERIC
    2018
    BOPA
    2018
    ESH MM
    2018
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

ASH 2018 and Multiple Myeloma View overview page

2:45
Myeloma XI trial: increased progression-free survival
Charlotte Pawlyn
1:28
MM has a bright future: highlights from ASH
Mark Bustoros
3:59
Promising combination of ixazomib, lenalidomide & dex in high-risk smoldering myeloma
Mark Bustoros
1:23
Melflufen and dex with bortezomib/daratumumab for myeloma: OP-104 study
Enrique Ocio
1:51
Predicting IMiD sensitivity in myeloma
Rafael Fonseca
0:57
High economic burden for progressive multiple myeloma: considering costs
Rafael Fonseca
3:11
Isatuximab plus VRd for newly diagnosed transplant-ineligible myeloma
Enrique Ocio
1:06
High treatment attrition in newly diagnosed multiple myeloma patients
Rafael Fonseca
1:59
Multiple myeloma musings: highlights from 2018 data
Joshua Richter
1:04
Current challenges for multiple myeloma therapy: 2, 3, 4-drug combinations
Joshua Richter
1:57
Pivotal STORM study: selinexor for penta-refractory multiple myeloma
Joshua Richter
04:22
Mohamad Mohty’s myeloma highlights from ASH 2018
Mohamad Mohty
04:11
An exciting era for CAR T-cell therapy
Mohamad Mohty
1:12
Hot topic: Geriatric Assessment in Hematology (GAH) scale
Raúl Córdoba
3:27
Understanding myeloma disease dissemination: are CTCs responsible?
Bruno Paiva
2:12
A step towards next-generation immune monitoring in multiple myeloma?
Bruno Paiva
  • 1
  • 2
  • 3
  • Next
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue
Video channels
  • Acute Lymphoblastic Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • Amyloidosis
  • Anemia
  • Aplastic Anemia
  • B-Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use